Cargando…

BRAF and beyond: Tailoring strategies for the individual melanoma patient

Until recently, options for therapy in metastatic melanoma were limited. The understanding of immune check-point blockade and the discovery of molecular pathways involving driver mutations like BRAF has transformed the therapeutic landscape in this disease. Ipilimumab was the first drug shown to imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarkowski, Anthony, Khushalani, Nikhil I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986540/
https://www.ncbi.nlm.nih.gov/pubmed/24737949
http://dx.doi.org/10.4103/1477-3163.126759